Kaur, Gurnoor, Bhatt, Ria, Chow, Yan-Ching
ORCID: 0009-0007-4891-8231, Siripanich, Chawalpat
ORCID: 0009-0006-7848-8669 and Ali, Faisal
ORCID: 0000-0002-8588-791X
(2025)
Calcitonin Gene-Related Peptide Inhibition: The Advent of Biologics in Rosacea.
Clinical and Experimental Dermatology, 50
(11).
pp. 2354-2355.
ISSN 0307-6938
Preview |
PDF (VOR)
- Published Version
Available under License Creative Commons Attribution. 531kB |
Official URL: https://doi.org/10.1093/ced%2Fllaf299
Abstract
Persistent facial erythema and flushing in rosacea remain challenging to treat with current therapies. A recent noteworthy open-label trial found that erenumab, a CGRP receptor inhibitor, significantly reduced moderate to extreme flushing and erythema in treatment-resistant patients, highlighting a novel neurovascular-targeted therapeutic approach.
Repository Staff Only: item control page
Tools
Tools